Sign In
Buy MLSS
$0.399
+0.0080 (+2.05%)
At Close: Jul 31, 2026
Milestone Scientific (NYSE:MLSS) Trading 3.1% Higher – Here’s What Happened
02:40am, Friday, 12'th Dec 2025
Milestone Scientific Inc. (NYSE: MLSS - Get Free Report) shares shot up 3.1% during mid-day trading on Thursday. The stock traded as high as $0.3685 and last traded at $0.3551. 203,137 shares were tra
Milestone Scientific (NYSE:MLSS) Shares Down 1.6% – Here’s Why
02:56am, Wednesday, 19'th Nov 2025
Shares of Milestone Scientific Inc. (NYSE: MLSS - Get Free Report) dropped 1.6% during mid-day trading on Tuesday. The company traded as low as $0.2929 and last traded at $0.3070. Approximately 873,43
Milestone Scientific Inc. (MLSS) Q3 2025 Earnings Call Transcript
11:01am, Friday, 14'th Nov 2025
Milestone Scientific Inc. ( MLSS ) Q3 2025 Earnings Call November 14, 2025 8:30 AM EST Company Participants Eric Hines - Chief Executive Officer, President & Director Keisha Harcum - Vice President of
Milestone Scientific Delivers Stable Revenue and Reduces Operating Expenses by Over $500 Thousand in the Third Quarter of 2025
04:00pm, Thursday, 13'th Nov 2025
ROSELAND, N.J., Nov. 13, 2025 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE: MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, to
Milestone Scientific Schedules Third Quarter 2025 Financial Results and Business Update Conference Call
02:15pm, Thursday, 13'th Nov 2025
ROSELAND, N.J., Nov. 13, 2025 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE:MLSS), a leading developer of computerized drug delivery instruments, that provide painless and precise injections, t
Milestone Scientific Highlights Operational Progress and Growth Initiatives Under New Leadership
07:50am, Tuesday, 14'th Oct 2025
Company outlines decisive initiatives to strengthen its dental and medical businesses, reduce operating expenses across the organization, and position Milestone Scientific for accelerated growth and i
Milestone Scientific Commits to Regaining NYSE American Compliance Following Notification
07:45am, Tuesday, 14'th Oct 2025
Notification has no immediate effect on the Company's listing or day-to-day operations Notification has no immediate effect on the Company's listing or day-to-day operations
Appointment strengthens Board expertise as Milestone Scientific drives commercial expansion and payer adoption of CompuFlo® in interventional pain management Appointment strengthens Board expertise a
Milestone Scientific Achieves 25% Increase in Revenue for the Second Quarter of 2025
04:15pm, Thursday, 14'th Aug 2025
Expands senior leadership team and board of directors to support next phase of growth Expands senior leadership team and board of directors to support next phase of growth
Milestone Scientific Schedules Second Quarter 2025 Financial Results and Business Update Conference Call
11:45am, Wednesday, 13'th Aug 2025
ROSELAND, N.J., Aug. 13, 2025 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE:MLSS), a leading developer of computerized drug delivery instruments, that provide painless and precise injections, to
Milestone Scientific Appoints Jason Papes as Senior Vice President, Global Head of Sales and Marketing
08:30am, Wednesday, 06'th Aug 2025
ROSELAND. N.J., Aug. 06, 2025 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE: MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, to
Milestone Scientific Appoints Eric C. Hines as Chief Executive Officer
08:30am, Friday, 01'st Aug 2025
Seasoned executive with proven track record driving growth and building customer focused teams to lead Milestone's next phase of commercial execution Seasoned executive with proven track record drivin
Milestone Scientific Commences Sales of CompuFlo® Epidural System at The Painless Center in Tenafly, New Jersey
08:30am, Thursday, 17'th Jul 2025
ROSELAND, N.J., July 17, 2025 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE: MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, to
Milestone Scientific Appoints Highly Accomplished MedTech Executive Shanth Thiyagalingam to Board of Directors
10:00am, Monday, 19'th May 2025
Brings Proven Commercial Leadership, Reimbursement Expertise, and Global Market Insight to Support Next Phase of Growth Across Medical and Dental Segments Brings Proven Commercial Leadership, Reimburs
Milestone Scientific Reports Revenue of $2.2 Million and Provides Business Update for the First Quarter of 2025
04:15pm, Thursday, 15'th May 2025
ROSELAND, N.J., May 15, 2025 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE: MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, tod
